File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Reply to 'Reduction of cirrhosis and hepatocellular carcinoma with antiviral therapy in chronic hepatitis B'

TitleReply to 'Reduction of cirrhosis and hepatocellular carcinoma with antiviral therapy in chronic hepatitis B'
Authors
Lai, CLYuen, RMF
Issue Date2013
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Citation
Hepatology, 2013, v. 58 n. 5, p. 1857 How to Cite?
DOI: http://dx.doi.org/10.1002/hep.26417
DescriptionReply to PMID 22806323 & 23463378 [Reduction of cirrhosis and hepatocellular carcinoma with antiviral therapy in chronic hepatitis B. Hepatology. 2013 Nov; 58(5):1856]
Persistent Identifierhttp://hdl.handle.net/10722/199154
ISSN
0270-9139
2023 Impact Factor: 12.9
2023 SCImago Journal Rankings: 5.011
ISI Accession Number ID
WOS:000326327600037

 

DC FieldValueLanguage
dc.contributor.authorLai, CLen_US
dc.contributor.authorYuen, RMFen_US
dc.date.accessioned2014-07-22T01:04:57Z-
dc.date.available2014-07-22T01:04:57Z-
dc.date.issued2013en_US
dc.identifier.citationHepatology, 2013, v. 58 n. 5, p. 1857en_US
dc.identifier.issn0270-9139en_US
dc.identifier.urihttp://hdl.handle.net/10722/199154-
dc.descriptionReply to PMID 22806323 & 23463378 [Reduction of cirrhosis and hepatocellular carcinoma with antiviral therapy in chronic hepatitis B. Hepatology. 2013 Nov; 58(5):1856]en_US
dc.languageengen_US
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/en_US
dc.relation.ispartofHepatologyen_US
dc.rightsHepatology. Copyright © John Wiley & Sons, Inc.en_US
dc.subject.meshAntiviral Agents - therapeutic useen_US
dc.subject.meshCarcinoma, Hepatocellular - prevention and controlen_US
dc.subject.meshHepatitis B - complicationsen_US
dc.subject.meshInterferon-alpha - therapeutic useen_US
dc.subject.meshLiver Neoplasms - prevention and controlen_US
dc.titleReply to 'Reduction of cirrhosis and hepatocellular carcinoma with antiviral therapy in chronic hepatitis B'en_US
dc.typeArticleen_US
dc.identifier.emailLai, CL: hrmelcl@hku.hken_US
dc.identifier.emailYuen, RMF: mfyuen@hku.hken_US
dc.identifier.authorityLai, CL=rp00314en_US
dc.identifier.authorityYuen, RMF=rp00479en_US
dc.identifier.doi10.1002/hep.26417en_US
dc.identifier.pmid23532941en_US
dc.identifier.scopuseid_2-s2.0-84887018305-
dc.identifier.hkuros230540en_US
dc.identifier.volume58en_US
dc.identifier.issue5en_US
dc.identifier.spage1857en_US
dc.identifier.epage1857en_US
dc.identifier.isiWOS:000326327600037-
dc.publisher.placeUnited Statesen_US
dc.identifier.issnl0270-9139-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats